Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.
ISRIV 1st Influenza Vaccine Group Meeting, March 31st - April 2nd, Siena, Italy
Alex Man, hVIVO’s Director Clinical Science R&D Operations, will be making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting. The event takes place between March 31st and April 2nd in Siena, Italy.
Alex Mann, will be presenting on Sunday, March 31st:
If you would like to make contact with Alex Mann, Director Clinical Science R&D Operations, and Reid Tripp, Executive Vice President, Business Development and Marketing, from hVIVO before or during the ISIRV event in Siena, please use the Contact Us page on this site.